Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics

5.1.1. Market Drivers

5.1.2. Market Restraints

5.1.3. Market Opportunities

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining power of suppliers

5.2.2. Bargaining power of buyers

5.2.3. Threat of substitute

5.2.4. Threat of new entrants

5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis

6.1.2. Key Strategies Adopted by Players

6.1.3. Vendor Landscape

6.1.3.1. List of Suppliers

6.1.3.2. List of Buyers

Chapter 7. Global Single-use Bioreactors Market, By Product

7.1. Single-use Bioreactors Market, by Product, 2022-2030

7.1.1. Single-use Bioreactor Systems

7.1.1.1. Market Revenue and Forecast (2017-2030)

7.1.2. Single-use Media Bags

7.1.2.1. Market Revenue and Forecast (2017-2030)

7.1.3. Single-use Filtration Assemblies

7.1.3.1. Market Revenue and Forecast (2017-2030)

7.1.4. Other Products

7.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 8. Global Single-use Bioreactors Market, By Type

8.1. Single-use Bioreactors Market, by Type, 2022-2030

8.1.1. Stirred-tank SUBs

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Bubble-column SUBs

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Wave-induced SUBs

8.1.3.1. Market Revenue and Forecast (2017-2030)

8.1.4. Other SUBs

8.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Single-use Bioreactors Market, By Type of Cell

9.1. Single-use Bioreactors Market, by Type of Cell, 2022-2030

9.1.1. Mammalian Cells

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Yeast Cells

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Bacterial Cells

9.1.3.1. Market Revenue and Forecast (2017-2030)

9.1.4. Others

9.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Single-use Bioreactors Market, By Molecule Type

10.1. Single-use Bioreactors Market, by Molecule Type, 2022-2030

10.1.1. Monoclonal Antibodies

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Vaccines

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. Stem Cells

10.1.3.1. Market Revenue and Forecast (2017-2030)

10.1.4. Gene Modified Cells

10.1.4.1. Market Revenue and Forecast (2017-2030)

10.1.5. Others

10.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Single-use Bioreactors Market, By Application

11.1. Single-use Bioreactors Market, by Application, 2022-2030

11.1.1. Research and Development (R&D) or Process Development

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Bioproduction

11.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Single-use Bioreactors Market, By End-Use

12.1. Single-use Bioreactors Market, by End-Use, 2022-2030

12.1.1. CROs & CMOs

12.1.1.1. Market Revenue and Forecast (2017-2030)

12.1.2. Pharmaceutical & Biopharmaceutical Companies

12.1.2.1. Market Revenue and Forecast (2017-2030)

12.1.3. Academic & Research Institutes

12.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 13. Global Single-use Bioreactors Market, By Usage Type

13.1. Single-use Bioreactors Market, by Usage Type, 2022-2030

13.1.1. Pilot-scale Production

13.1.1.1. Market Revenue and Forecast (2017-2030)

13.1.2. Lab-scale Production

13.1.2.1. Market Revenue and Forecast (2017-2030)

13.1.3. Large-scale Production

13.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 14. Global Single-use Bioreactors Market, Regional Estimates and Trend Forecast

14.1. North America

14.1.1. Market Revenue and Forecast, by Product (2017-2030)

14.1.2. Market Revenue and Forecast, by Type (2017-2030)

14.1.3. Market Revenue and Forecast, by Type of Cell (2017-2030)

14.1.4. Market Revenue and Forecast, by Molecule Type (2017-2030)

14.1.5. Market Revenue and Forecast, by Application (2017-2030)

14.1.6. Market Revenue and Forecast, by Usage Type (2017-2030)

14.1.7. Market Revenue and Forecast, by End-Use (2017-2030)

14.1.8. U.S.

14.1.8.1. Market Revenue and Forecast, by Product (2017-2030)

14.1.8.2. Market Revenue and Forecast, by Type (2017-2030)

14.1.8.3. Market Revenue and Forecast, by Type of Cell (2017-2030)

14.1.8.4. Market Revenue and Forecast, by Molecule Type (2017-2030)

14.1.8.5. Market Revenue and Forecast, by Application (2017-2030)

14.1.8.6. Market Revenue and Forecast, by Usage Type (2017-2030)

14.1.8.7. Market Revenue and Forecast, by End-Use (2017-2030)

14.1.9. Rest of North America

14.1.9.1. Market Revenue and Forecast, by Product (2017-2030)

14.1.9.2. Market Revenue and Forecast, by Type (2017-2030)

14.1.9.3. Market Revenue and Forecast, by Type of Cell (2017-2030)

14.1.9.4. Market Revenue and Forecast, by Molecule Type (2017-2030)

14.1.9.5. Market Revenue and Forecast, by Application (2017-2030)

14.1.9.6. Market Revenue and Forecast, by Usage Type (2017-2030)

14.1.9.7. Market Revenue and Forecast, by End-Use (2017-2030)

14.2. Europe

14.2.1. Market Revenue and Forecast, by Product (2017-2030)

14.2.2. Market Revenue and Forecast, by Type (2017-2030)

14.2.3. Market Revenue and Forecast, by Type of Cell (2017-2030)

14.2.4. Market Revenue and Forecast, by Molecule Type (2017-2030)

14.2.5. Market Revenue and Forecast, by Application (2017-2030)

14.2.6. Market Revenue and Forecast, by Usage Type (2017-2030)

14.2.7. Market Revenue and Forecast, by End-Use (2017-2030)

14.2.8. UK

14.2.8.1. Market Revenue and Forecast, by Product (2017-2030)

14.2.8.2. Market Revenue and Forecast, by Type (2017-2030)

14.2.8.3. Market Revenue and Forecast, by Type of Cell (2017-2030)

14.2.8.4. Market Revenue and Forecast, by Molecule Type (2017-2030)

14.2.8.5. Market Revenue and Forecast, by Application (2017-2030)

14.2.8.6. Market Revenue and Forecast, by Usage Type (2017-2030)

14.2.8.7. Market Revenue and Forecast, by End-Use (2017-2030)

14.2.9. Germany

14.2.9.1. Market Revenue and Forecast, by Product (2017-2030)

14.2.9.2. Market Revenue and Forecast, by Type (2017-2030)

14.2.9.3. Market Revenue and Forecast, by Type of Cell (2017-2030)

14.2.9.4. Market Revenue and Forecast, by Molecule Type (2017-2030)

14.2.9.5. Market Revenue and Forecast, by Application (2017-2030)

14.2.9.6. Market Revenue and Forecast, by Usage Type (2017-2030)

14.2.9.7. Market Revenue and Forecast, by End-Use (2017-2030)

14.2.10. France

14.2.10.1. Market Revenue and Forecast, by Product (2017-2030)

14.2.10.2. Market Revenue and Forecast, by Type (2017-2030)

14.2.10.3. Market Revenue and Forecast, by Type of Cell (2017-2030)

14.2.10.4. Market Revenue and Forecast, by Molecule Type (2017-2030)

14.2.10.5. Market Revenue and Forecast, by Application (2017-2030)

14.2.10.6. Market Revenue and Forecast, by Usage Type (2017-2030)

14.2.10.7. Market Revenue and Forecast, by End-Use (2017-2030)

14.2.11. Rest of Europe

14.2.11.1. Market Revenue and Forecast, by Product (2017-2030)

14.2.11.2. Market Revenue and Forecast, by Type (2017-2030)

14.2.11.3. Market Revenue and Forecast, by Type of Cell (2017-2030)

14.2.11.4. Market Revenue and Forecast, by Molecule Type (2017-2030)

14.2.11.5. Market Revenue and Forecast, by Application (2017-2030)

14.2.11.6. Market Revenue and Forecast, by Usage Type (2017-2030)

14.2.11.7. Market Revenue and Forecast, by End-Use (2017-2030)

14.3. APAC

14.3.1. Market Revenue and Forecast, by Product (2017-2030)

14.3.2. Market Revenue and Forecast, by Type (2017-2030)

14.3.3. Market Revenue and Forecast, by Type of Cell (2017-2030)

14.3.4. Market Revenue and Forecast, by Molecule Type (2017-2030)

14.3.5. Market Revenue and Forecast, by Application (2017-2030)

14.3.6. Market Revenue and Forecast, by Usage Type (2017-2030)

14.3.7. Market Revenue and Forecast, by End-Use (2017-2030)

14.3.8. India

14.3.8.1. Market Revenue and Forecast, by Product (2017-2030)

14.3.8.2. Market Revenue and Forecast, by Type (2017-2030)

14.3.8.3. Market Revenue and Forecast, by Type of Cell (2017-2030)

14.3.8.4. Market Revenue and Forecast, by Molecule Type (2017-2030)

14.3.8.5. Market Revenue and Forecast, by Application (2017-2030)

14.3.8.6. Market Revenue and Forecast, by Usage Type (2017-2030)

14.3.8.7. Market Revenue and Forecast, by End-Use (2017-2030)

14.3.9. China

14.3.9.1. Market Revenue and Forecast, by Product (2017-2030)

14.3.9.2. Market Revenue and Forecast, by Type (2017-2030)

14.3.9.3. Market Revenue and Forecast, by Type of Cell (2017-2030)

14.3.9.4. Market Revenue and Forecast, by Molecule Type (2017-2030)

14.3.9.5. Market Revenue and Forecast, by Application (2017-2030)

14.3.9.6. Market Revenue and Forecast, by Usage Type (2017-2030)

14.3.9.7. Market Revenue and Forecast, by End-Use (2017-2030)

14.3.10. Japan

14.3.10.1. Market Revenue and Forecast, by Product (2017-2030)

14.3.10.2. Market Revenue and Forecast, by Type (2017-2030)

14.3.10.3. Market Revenue and Forecast, by Type of Cell (2017-2030)

14.3.10.4. Market Revenue and Forecast, by Molecule Type (2017-2030)

14.3.10.5. Market Revenue and Forecast, by Application (2017-2030)

14.3.10.6. Market Revenue and Forecast, by Usage Type (2017-2030)

14.3.10.7. Market Revenue and Forecast, by End-Use (2017-2030)

14.3.11. Rest of APAC

14.3.11.1. Market Revenue and Forecast, by Product (2017-2030)

14.3.11.2. Market Revenue and Forecast, by Type (2017-2030)

14.3.11.3. Market Revenue and Forecast, by Type of Cell (2017-2030)

14.3.11.4. Market Revenue and Forecast, by Molecule Type (2017-2030)

14.3.11.5. Market Revenue and Forecast, by Application (2017-2030)

14.3.11.6. Market Revenue and Forecast, by Usage Type (2017-2030)

14.3.11.7. Market Revenue and Forecast, by End-Use (2017-2030)

14.4. MEA

14.4.1. Market Revenue and Forecast, by Product (2017-2030)

14.4.2. Market Revenue and Forecast, by Type (2017-2030)

14.4.3. Market Revenue and Forecast, by Type of Cell (2017-2030)

14.4.4. Market Revenue and Forecast, by Molecule Type (2017-2030)

14.4.5. Market Revenue and Forecast, by Application (2017-2030)

14.4.6. Market Revenue and Forecast, by Usage Type (2017-2030)

14.4.7. Market Revenue and Forecast, by End-Use (2017-2030)

14.4.8. GCC

14.4.8.1. Market Revenue and Forecast, by Product (2017-2030)

14.4.8.2. Market Revenue and Forecast, by Type (2017-2030)

14.4.8.3. Market Revenue and Forecast, by Type of Cell (2017-2030)

14.4.8.4. Market Revenue and Forecast, by Molecule Type (2017-2030)

14.4.8.5. Market Revenue and Forecast, by Application (2017-2030)

14.4.8.6. Market Revenue and Forecast, by Usage Type (2017-2030)

14.4.8.7. Market Revenue and Forecast, by End-Use (2017-2030)

14.4.9. North Africa

14.4.9.1. Market Revenue and Forecast, by Product (2017-2030)

14.4.9.2. Market Revenue and Forecast, by Type (2017-2030)

14.4.9.3. Market Revenue and Forecast, by Type of Cell (2017-2030)

14.4.9.4. Market Revenue and Forecast, by Molecule Type (2017-2030)

14.4.9.5. Market Revenue and Forecast, by Application (2017-2030)

14.4.9.6. Market Revenue and Forecast, by Usage Type (2017-2030)

14.4.9.7. Market Revenue and Forecast, by End-Use (2017-2030)

14.4.10. South Africa

14.4.10.1. Market Revenue and Forecast, by Product (2017-2030)

14.4.10.2. Market Revenue and Forecast, by Type (2017-2030)

14.4.10.3. Market Revenue and Forecast, by Type of Cell (2017-2030)

14.4.10.4. Market Revenue and Forecast, by Molecule Type (2017-2030)

14.4.10.5. Market Revenue and Forecast, by Application (2017-2030)

14.4.10.6. Market Revenue and Forecast, by Usage Type (2017-2030)

14.4.10.7. Market Revenue and Forecast, by End-Use (2017-2030)

14.4.11. Rest of MEA

14.4.11.1. Market Revenue and Forecast, by Product (2017-2030)

14.4.11.2. Market Revenue and Forecast, by Type (2017-2030)

14.4.11.3. Market Revenue and Forecast, by Type of Cell (2017-2030)

14.4.11.4. Market Revenue and Forecast, by Molecule Type (2017-2030)

14.4.11.5. Market Revenue and Forecast, by Application (2017-2030)

14.4.11.6. Market Revenue and Forecast, by Usage Type (2017-2030)

14.4.11.7. Market Revenue and Forecast, by End-Use (2017-2030)

14.5. Latin America

14.5.1. Market Revenue and Forecast, by Product (2017-2030)

14.5.2. Market Revenue and Forecast, by Type (2017-2030)

14.5.3. Market Revenue and Forecast, by Type of Cell (2017-2030)

14.5.4. Market Revenue and Forecast, by Molecule Type (2017-2030)

14.5.5. Market Revenue and Forecast, by Application (2017-2030)

14.5.6. Market Revenue and Forecast, by Usage Type (2017-2030)

14.5.7. Market Revenue and Forecast, by End-Use (2017-2030)

14.5.8. Brazil

14.5.8.1. Market Revenue and Forecast, by Product (2017-2030)

14.5.8.2. Market Revenue and Forecast, by Type (2017-2030)

14.5.8.3. Market Revenue and Forecast, by Type of Cell (2017-2030)

14.5.8.4. Market Revenue and Forecast, by Molecule Type (2017-2030)

14.5.8.5. Market Revenue and Forecast, by Application (2017-2030)

14.5.8.6. Market Revenue and Forecast, by Usage Type (2017-2030)

14.5.8.7. Market Revenue and Forecast, by End-Use (2017-2030)

14.5.9. Rest of LATAM

14.5.9.1. Market Revenue and Forecast, by Product (2017-2030)

14.5.9.2. Market Revenue and Forecast, by Type (2017-2030)

14.5.9.3. Market Revenue and Forecast, by Type of Cell (2017-2030)

14.5.9.4. Market Revenue and Forecast, by Molecule Type (2017-2030)

14.5.9.5. Market Revenue and Forecast, by Application (2017-2030)

14.5.9.6. Market Revenue and Forecast, by Usage Type (2017-2030)

14.5.9.7. Market Revenue and Forecast, by End-Use (2017-2030)

Chapter 15. Company Profiles

15.1. ABEC Inc.

15.1.1. Company Overview

15.1.2. Product Offerings

15.1.3. Financial Performance

15.1.4. Recent Initiatives

15.2. Able Corporation & Biott Corporation (Japan)

15.2.1. Company Overview

15.2.2. Product Offerings

15.2.3. Financial Performance

15.2.4. Recent Initiatives

15.3. Applikon Biotechnology B.V.

15.3.1. Company Overview

15.3.2. Product Offerings

15.3.3. Financial Performance

15.3.4. Recent Initiatives

15.4. Aptus bioreactors.

15.4.1. Company Overview

15.4.2. Product Offerings

15.4.3. Financial Performance

15.4.4. Recent Initiatives

15.5 Cell culture company

15.5.1. Company Overview

15.5.2. Product Offerings

15.5.3. Financial Performance

15.5.4. Recent Initiatives

15.6. Cellexus Ltd

15.6.1. Company Overview

15.6.2. Product Offerings

15.6.3. Financial Performance

15.6.4. Recent Initiatives

15.7. Celltainer Biotech BV (Netherlands)

15.7.1. Company Overview

15.7.2. Product Offerings

15.7.3. Financial Performance

15.7.4. Recent Initiatives

15.8. CESCO Bioengineering Co., Ltd.

15.8.1. Company Overview

15.8.2. Product Offerings

15.8.3. Financial Performance

15.8.4. Recent Initiatives

15.9. Danaher Corporation

15.9.1. Company Overview

15.9.2. Product Offerings

15.9.3. Financial Performance

15.9.4. Recent Initiatives

15.10. Distek Inc. (US)

15.10.1. Company Overview

15.10.2. Product Offerings

15.10.3. Financial Performance

15.10.4. Recent Initiatives

Chapter 16. Research Methodology

16.1. Primary Research

16.2. Secondary Research

16.3. Assumptions

Chapter 17. Appendix

17.1. About Us

17.2. Glossary of Terms